Sign in
Not yet recruitingNo phase

Exploring the Efficacy of Accelerated Transcranial Direct Current Stimulation (tDCS) as Adjunct to Pharmacotherapy in the Treatment of Obsessive-compulsive Disorder

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
60 people, planned
Started
11 Aug 2025
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • high-definition transcranial direct current stimulation
  • Sham tDCS
Record updated
11 August 2025

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age 18-60 years old, Han ethnicity, right-handed
  • DSM-5 criteria for OCD
  • Y-BOCS total score ≥16, receiving stable medication for at least 4 weeks before tDCS stimulation
  • Years of education ≥9

Who cannot take part

  • Previous treatment with electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS), or transcranial direct current stimulation (tDCS)
  • Any axis I psychiatric disorder comorbidity
  • Severe somatic diseases or any physical conditions that may induce epilepsy or intracranial hypertension, including cardiovascular and respiratory diseases, etc
  • History of neurological disorders (e.g., epilepsy, cerebrovascular accidents) or traumatic brain injury/brain surgery
  • Implantation of intracranial stents, cardiac pacemakers, coronary stents, cochlear implants, or other internal medical devices
  • Severe obsessive-compulsive symptoms that render the patient unable to complete required assessment procedures
  • Women who are pregnant or planning to become pregnant in the near future
  • Serious suicide risks

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will evaluate the decision-making ability and therapeutic effects of accelerated Transcranial Direct Current Stimulation (tDCS) as adjunct to pharmacotherapy in obsessive-compulsive disorder (OCD) patients, and the underlying neural mechanism by EEG and MRI.

The 2 groups in the trial

  • active tDCSExisting treatment, for comparison

    Cathode transcranial direct current stimulation over the right OFC will be applied four times a day (2 hours interval), 5 days a week, for 1 week.

    Treatment: high-definition transcranial direct current stimulation

  • sham tDCSSham treatment, for comparison

    The sham transcranial direct current stimulation over the right OFC will be applied four times a day (2 hours interval), 5 days a week, for 1 week.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exploring the Efficacy of Accelerated Transcranial Direct Current Stimulation (tDCS) as Adjunct to Pharmacotherapy in the Treatment of Obsessive-compulsive Disorder: A Randomized Controlled Trial Using High-resolution MRI
Fit questions
Built from NCT07115615, who can take part
Record updated
11 August 2025